Exchange Traded Concepts’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.36M | Buy |
13,932
+7,697
| +123% | +$1.86M | 0.04% | 382 |
|
|
2025
Q1 | $1.52M | Buy |
6,235
+3,973
| +176% | +$968K | 0.03% | 443 |
|
|
2024
Q4 | $743K | Sell |
2,262
-10
| -0.4% | -$3.29K | 0.01% | 699 |
|
|
2024
Q3 | $760K | Sell |
2,272
-884
| -28% | -$296K | 0.02% | 649 |
|
|
2024
Q2 | $862K | Buy |
3,156
+154
| +5% | +$42.1K | 0.02% | 484 |
|
|
2024
Q1 | $1.04M | Buy |
3,002
+355
| +13% | +$123K | 0.03% | 431 |
|
|
2023
Q4 | $855K | Sell |
2,647
-491
| -16% | -$159K | 0.02% | 437 |
|
|
2023
Q3 | $1.12M | Sell |
3,138
-708
| -18% | -$254K | 0.03% | 364 |
|
|
2023
Q2 | $1.46M | Buy |
3,846
+961
| +33% | +$364K | 0.04% | 321 |
|
|
2023
Q1 | $1.38M | Sell |
2,885
-911
| -24% | -$436K | 0.04% | 268 |
|
|
2022
Q4 | $1.6M | Buy |
3,796
+807
| +27% | +$339K | 0.05% | 221 |
|
|
2022
Q3 | $1.25M | Buy |
2,989
+188
| +7% | +$78.4K | 0.04% | 219 |
|
|
2022
Q2 | $1.39M | Sell |
2,801
-644
| -19% | -$319K | 0.04% | 227 |
|
|
2022
Q1 | $1.94M | Buy |
3,445
+46
| +1% | +$25.9K | 0.04% | 230 |
|
|
2021
Q4 | $2.57M | Sell |
3,399
-482
| -12% | -$364K | 0.05% | 220 |
|
|
2021
Q3 | $2.9M | Sell |
3,881
-1,733
| -31% | -$1.29M | 0.07% | 192 |
|
|
2021
Q2 | $3.62M | Buy |
5,614
+338
| +6% | +$218K | 0.11% | 136 |
|
|
2021
Q1 | $3.01M | Buy |
5,276
+1,701
| +48% | +$971K | 0.11% | 129 |
|
|
2020
Q4 | $2.08M | Buy |
3,575
+1,642
| +85% | +$957K | 0.1% | 139 |
|
|
2020
Q3 | $996K | Buy |
1,933
+578
| +43% | +$298K | 0.06% | 171 |
|
|
2020
Q2 | $612K | Buy |
1,355
+977
| +258% | +$441K | 0.1% | 168 |
|
|
2020
Q1 | $133K | Buy |
378
+150
| +66% | +$52.8K | 0.07% | 233 |
|
|
2019
Q4 | $84K | Buy |
+228
| New | +$84K | 0.02% | 223 |
|